NCT01650168View on ClinicalTrials.gov

Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)

CompletedOBSERVATIONAL
Enrollment

101,498

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Contraception
Trial Locations (1)

Unknown

Center for Epidemiology and Health Research Berlin, Berlin

Sponsors

Collaborators (1)

Theramex
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Theramex

INDUSTRY

lead

Center for Epidemiology and Health Research, Germany

OTHER

NCT01650168 - Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg) | Biotech Hunter | Biotech Hunter